$10.79
-0.33(-2.97%)Stock price, Market closedPrevious Close: $11.119999885559082$3.1 B
FOLD Mkt cap, 24-Jun-2022$66.4 M
Amicus Therapeutics Revenue Q1, 2021Amicus Therapeutics Gross profit (Q1, 2021)59.9 M
Amicus Therapeutics Gross profit margin (Q1, 2021), %90.2%
Amicus Therapeutics Net income (Q1, 2021)-65.7 M
Amicus Therapeutics EBIT (Q1, 2021)-53.1 M
Amicus Therapeutics Cash, 31-Mar-2021184.8 M
Amicus Therapeutics EV3.4 B